Related Experiment Video
Updated: Jan 21, 2026

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody mAb by Neutralizing TNF Using an In Vitro Bioanalytical Method
Published on: September 16, 2017
Cutaneous leishmaniasis associated with TNF-α blockers: a case report
Pelayo Nieto Gómez1, Inmaculada Casas Hidalgo1, María de la Paz Casas Hidalgo2
1Farmacia Hospitalaria, Hospital Universitario San Cecilio, Granada, Spain.
Tumour necrosis factor alpha (TNF-α) inhibitors like infliximab can trigger leishmaniasis, a parasitic infection. Prompt diagnosis and treatment with liposomal amphotericin B led to complete recovery in a psoriatic arthritis patient.
Area of Science:
- Immunology
- Infectious Diseases
- Dermatology
Background:
- Leishmaniasis is a chronic protozoan disease prevalent in Mediterranean regions.
- Tumour necrosis factor alpha (TNF-α) is crucial for host defense against Leishmania parasites.
- TNF-α inhibitors are used to treat autoimmune conditions like psoriatic arthritis.
Related Concept Videos
Depolarizing Blockers: Pharmocokinetics
Data Reporting and Recording
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Types of Reports I: Hands-off Report
Following are the key components and categories of hand-off reports:
Purpose and Process:
Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...

